Pharming Group N.V.
PHGUF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $113 | $92 | $60 | $55 |
| Short-Term Investments | $29 | $34 | $47 | $113 |
| Receivables | $37 | $53 | $47 | $50 |
| Inventory | $57 | $64 | $59 | $56 |
| Other Curr. Assets | $1 | $3 | $0 | $5 |
| Total Curr. Assets | $236 | $246 | $214 | $278 |
| Property Plant & Equip (Net) | $21 | $25 | $24 | $24 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $115 | $136 | $139 | $61 |
| Long-Term Investments | $6 | $7 | $6 | $4 |
| Tax Assets | $0 | $31 | $18 | $31 |
| Other NC Assets | $25 | $2 | $2 | $2 |
| Total NC Assets | $167 | $200 | $189 | $122 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $404 | $446 | $403 | $400 |
| Liabilities | – | – | – | – |
| Payables | $67 | $78 | $69 | $7 |
| Short-Term Debt | $8 | $10 | $9 | $7 |
| Tax Payable | $0 | $0 | $0 | $3 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | -$0 | $0 | $0 | $57 |
| Total Curr. Liab. | $75 | $88 | $78 | $74 |
| LT Debt | $103 | $119 | $110 | $105 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | -$0 | $0 | $0 | $0 |
| Total NC Liab. | $103 | $119 | $110 | $105 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $28 | $32 | $31 | $30 |
| Total Liabilities | $178 | $207 | $188 | $179 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $7 | $8 | $8 | $8 |
| Retained Earnings | -$214 | -$286 | -$293 | -$275 |
| AOCI | $0 | $26 | $9 | -$0 |
| Other Equity | $432 | $492 | $490 | $489 |
| Total Equity | $225 | $240 | $214 | $221 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $1 | $0 |
| Total Liab. & Tot. Equity | $404 | $446 | $403 | $400 |
| Net Debt | -$1 | $36 | $59 | $57 |